U.S. Rare Disease Diagnostics Market Projected to Reach $28.57 Billion by 2032, Growing at a CAGR of 9.3%
In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market …